Table 3.
Univariate and Multivariate Analysis Associating with Flare.
| Parameters | Univariate | Multivariate | ||||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |||||
| HCQ use | 0.12 (0.007-0.61) | <0.01 | 0.14 (0.007-0.71) | 0.01 | ||||
| No drugs | 5.29 (1.37-20.41) | 0.02 | 4.21 (1.09-16.36) | 0.04 | ||||
| IS use | 0.25 (0.01-1.35) | 0.12 | ||||||
| Age (year) | 1.02 (0.99-1.05) | 0.17 | ||||||
| Female | 1.25 (0.27-4.37) | 0.74 | ||||||
| Disease duration (months) | 1.00 (0.99-1.00) | 0.17 | ||||||
| WBC (×1,000/μL) | 1.00 (1.00-1.01) | 0.99 | - | - | ||||
| SLEDAI | 1.03 (0.91-1.18) | 0.62 | - | - | ||||
HCQ: hydroxychloroquine, IS: immunosuppressant, WBC: white blood cells, SLEDAI: Systemic Lupus Erythematosus Disease Activity Index